339 related articles for article (PubMed ID: 23321702)
21. Controlled-Release Oxycodone as "Gold Standard" for Postoperative Pain Therapy in Patients Undergoing Video-Assisted Thoracic Surgery or Thoracoscopy: A Retrospective Evaluation of 788 Cases.
Kampe S; Weinreich G; Darr C; Stamatis G; Hachenberg T
Thorac Cardiovasc Surg; 2015 Sep; 63(6):510-3. PubMed ID: 25602848
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer.
Kampe S; Warm M; Kaufmann J; Hundegger S; Mellinghoff H; Kiencke P
Curr Med Res Opin; 2004; 20(2):199-202. PubMed ID: 15006014
[TBL] [Abstract][Full Text] [Related]
23. Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting.
Ginsberg B; Sinatra RS; Adler LJ; Crews JC; Hord AH; Laurito CE; Ashburn MA
Pain Med; 2003 Mar; 4(1):31-8. PubMed ID: 12873276
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol.
Badeaux J; Bonanno L; Au H
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):27-38. PubMed ID: 26447005
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
26. Oxycodone-paracetamol tablet exhibits increased analgesic efficacy for acute postoperative pain, higher satisfaction and comparable safety profiles compared with celecoxib in patients underwent arthroscopic knee surgery.
Liu J; Di J; Zhang Y; Xing E
Inflammopharmacology; 2021 Aug; 29(4):1091-1099. PubMed ID: 34181148
[TBL] [Abstract][Full Text] [Related]
27. Preoperative administration of controlled-release oxycodone as a transition opioid for total intravenous anaesthesia in pain control after laparoscopic cholecystectomy.
Fanelli G; Ghisi D; Berti M; Troglio R; Ortu A; Consigli C; Casati A
Surg Endosc; 2008 Oct; 22(10):2220-8. PubMed ID: 18626707
[TBL] [Abstract][Full Text] [Related]
28. Oral oxycodone offers equivalent analgesia to intravenous patient-controlled analgesia after total hip replacement: a randomized, single-centre, non-blinded, non-inferiority study.
Rothwell MP; Pearson D; Hunter JD; Mitchell PA; Graham-Woollard T; Goodwin L; Dunn G
Br J Anaesth; 2011 Jun; 106(6):865-72. PubMed ID: 21490024
[TBL] [Abstract][Full Text] [Related]
29. Premedication with controlled-release oxycodone does not improve management of postoperative pain after day-case gynaecological laparoscopic surgery.
Jokela R; Ahonen J; Valjus M; Seppälä T; Korttila K
Br J Anaesth; 2007 Feb; 98(2):255-60. PubMed ID: 17218374
[TBL] [Abstract][Full Text] [Related]
30. Epidural oxycodone or morphine following gynaecological surgery.
Yanagidate F; Dohi S
Br J Anaesth; 2004 Sep; 93(3):362-7. PubMed ID: 15220165
[TBL] [Abstract][Full Text] [Related]
31. Patient-Controlled Analgesia (PCA): Intravenous Administration (IV-PCA) versus Oral Administration (Oral-PCA) by Using a Novel Device (PCoA® Acute) for Hospitalized Patients with Acute Postoperative Pain-A Comparative Retrospective Study.
Wirz S; Seidensticker S; Shtrichman R
Pain Res Manag; 2021; 2021():2542010. PubMed ID: 34055117
[TBL] [Abstract][Full Text] [Related]
32. Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study.
Vorsanger GJ; Klopfer AM; Xiang J; Benson CJ; Moskovitz BL; Rosenthal NR
J Opioid Manag; 2013; 9(4):281-90. PubMed ID: 24353022
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
Inoue S; Saito Y; Tsuneto S; Aruga E; Takahashi H; Uemori M
Jpn J Clin Oncol; 2018 Jun; 48(6):542-547. PubMed ID: 29659913
[TBL] [Abstract][Full Text] [Related]
34. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
35. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
36. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
37. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study.
Yu S; Shen W; Yu L; Hou Y; Han J; Richards HM
J Pain; 2014 Aug; 15(8):835-44. PubMed ID: 24846822
[TBL] [Abstract][Full Text] [Related]
39. Controlled-release oxycodone for the management of pediatric postoperative pain.
Czarnecki ML; Jandrisevits MD; Theiler SC; Huth MM; Weisman SJ
J Pain Symptom Manage; 2004 Apr; 27(4):379-86. PubMed ID: 15112683
[TBL] [Abstract][Full Text] [Related]
40. A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.
Binsfeld H; Szczepanski L; Waechter S; Richarz U; Sabatowski R
Pain Pract; 2010; 10(5):404-15. PubMed ID: 20384968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
